Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.

Nowicka-Sans B, Gong YF, McAuliffe B, Dicker I, Ho HT, Zhou N, Eggers B, Lin PF, Ray N, Wind-Rotolo M, Zhu L, Majumdar A, Stock D, Lataillade M, Hanna GJ, Matiskella JD, Ueda Y, Wang T, Kadow JF, Meanwell NA, Krystal M.

Antimicrob Agents Chemother. 2012 Jul;56(7):3498-507. doi: 10.1128/AAC.00426-12. Epub 2012 Apr 30.

2.

A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.

Wang HG, Williams RE, Lin PF.

Curr Pharm Des. 2004;10(15):1785-93. Review.

PMID:
15180540
3.

Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806.

Liu T, Huang B, Zhan P, De Clercq E, Liu X.

Eur J Med Chem. 2014 Oct 30;86:481-90. doi: 10.1016/j.ejmech.2014.09.012. Epub 2014 Sep 6. Review.

PMID:
25203778
4.

Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.

Kadow J, Wang HG, Lin PF.

Curr Opin Investig Drugs. 2006 Aug;7(8):721-6. Review.

PMID:
16955683
5.

CD4 down-modulating compounds with potent anti-HIV activity.

Vermeire K, Schols D, Bell TW.

Curr Pharm Des. 2004;10(15):1795-803. Review.

PMID:
15180541
6.

Pyrroloaryls and pyrroloheteroaryls: Inhibitors of the HIV fusion/attachment, reverse transcriptase and integrase.

Patel RV, Park SW.

Bioorg Med Chem. 2015 Sep 1;23(17):5247-63. doi: 10.1016/j.bmc.2015.06.016. Epub 2015 Jun 14. Review.

PMID:
26116177
7.

HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Acharya P, Lusvarghi S, Bewley CA, Kwong PD.

Expert Opin Ther Targets. 2015 Jun;19(6):765-83. doi: 10.1517/14728222.2015.1010513. Epub 2015 Feb 27. Review.

8.

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.

PMID:
12662125
9.

New advances in HIV entry inhibitors development.

Rusconi S, Scozzafava A, Mastrolorenzo A, Supuran CT.

Curr Drug Targets Infect Disord. 2004 Dec;4(4):339-55. Review.

PMID:
15578975
10.

Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.

Witvrouw M, De Clercq E.

Gen Pharmacol. 1997 Oct;29(4):497-511. Review.

PMID:
9352294

Supplemental Content

Support Center